As of 2024-12-15, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is
-5.18 USD. This TERN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 6.73 USD, the upside of Terns Pharmaceuticals Inc is
-177.03%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-5.18 USD
Intrinsic Value
TERN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-5.18 - -5.18 |
-5.18 |
-177.03% |
| P/E |
(25.82) - (30.28) |
(27.81) |
-513.3% |
| DDM - Stable |
(11.54) - (81.63) |
(46.59) |
-792.3% |
| DDM - Multi |
(11.46) - (63.91) |
(19.52) |
-390.1% |
TERN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
571.65 |
| Beta |
2.23 |
| Outstanding shares (mil) |
84.94 |
| Enterprise Value (mil) |
301.51 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.72% |
| Cost of Debt |
5.00% |
| WACC |
6.34% |